Literature DB >> 23239825

Differentiation of opioid drug effects by hierarchical multi-site phosphorylation.

Sascha Just1, Susann Illing, Michelle Trester-Zedlitz, Elaine K Lau, Sarah J Kotowski, Elke Miess, Anika Mann, Christian Doll, Jonathan C Trinidad, Alma L Burlingame, Mark von Zastrow, Stefan Schulz.   

Abstract

Differences in the ability of opioid drugs to promote regulated endocytosis of μ-opioid receptors are related to their tendency to produce drug tolerance and dependence. Here we show that drug-specific differences in receptor internalization are determined by a conserved, 10-residue sequence in the receptor's carboxyl-terminal cytoplasmic tail. Diverse opioids induce receptor phosphorylation at serine (S)375, present in the middle of this sequence, but opioids differ markedly in their ability to drive higher-order phosphorylation on flanking residues [threonine (T)370, T376, and T379]. Multi-phosphorylation is required for the endocytosis-promoting activity of this sequence and occurs both sequentially and hierarchically, with S375 representing the initiating site. Higher-order phosphorylation involving T370, T376, and T379 specifically requires GRK2/3 isoforms, and the same sequence controls opioid receptor internalization in neurons. These results reveal a biochemical mechanism differentiating the endocytic activity of opioid drugs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23239825      PMCID: PMC3583494          DOI: 10.1124/mol.112.082875

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  27 in total

1.  Role for the C-terminus in agonist-induced mu opioid receptor phosphorylation and desensitization.

Authors:  H B Deng; Y Yu; Y Pak; B F O'Dowd; S R George; C K Surratt; G R Uhl; J B Wang
Journal:  Biochemistry       Date:  2000-05-09       Impact factor: 3.162

2.  Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication.

Authors:  P Nash; X Tang; S Orlicky; Q Chen; F B Gertler; M D Mendenhall; F Sicheri; T Pawson; M Tyers
Journal:  Nature       Date:  2001-11-29       Impact factor: 49.962

3.  C-terminal splice variants of the mouse mu-opioid receptor differ in morphine-induced internalization and receptor resensitization.

Authors:  T Koch; S Schulz; M Pfeiffer; M Klutzny; H Schröder; E Kahl; V Höllt
Journal:  J Biol Chem       Date:  2001-05-18       Impact factor: 5.157

4.  Deciphering µ-opioid receptor phosphorylation and dephosphorylation in HEK293 cells.

Authors:  Christian Doll; Florian Pöll; Kenneth Peuker; Anastasia Loktev; Laura Glück; Stefan Schulz
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

5.  Analgesic tolerance to high-efficacy agonists but not to morphine is diminished in phosphorylation-deficient S375A μ-opioid receptor knock-in mice.

Authors:  Gisela Grecksch; Sascha Just; Claudia Pierstorff; Anne-Katja Imhof; Laura Glück; Christian Doll; Amelie Lupp; Axel Becker; Thomas Koch; Ralf Stumm; Volker Höllt; Stefan Schulz
Journal:  J Neurosci       Date:  2011-09-28       Impact factor: 6.167

Review 6.  Role of receptor internalization in opioid tolerance and dependence.

Authors:  Thomas Koch; Volker Höllt
Journal:  Pharmacol Ther       Date:  2007-11-17       Impact factor: 12.310

7.  Rapid dephosphorylation of G protein-coupled receptors by protein phosphatase 1β is required for termination of β-arrestin-dependent signaling.

Authors:  Florian Pöll; Christian Doll; Stefan Schulz
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

8.  Quantitative encoding of the effect of a partial agonist on individual opioid receptors by multisite phosphorylation and threshold detection.

Authors:  Elaine K Lau; Michelle Trester-Zedlitz; Jonathan C Trinidad; Sarah J Kotowski; Andrew N Krutchinsky; Alma L Burlingame; Mark von Zastrow
Journal:  Sci Signal       Date:  2011-08-09       Impact factor: 8.192

Review 9.  The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence.

Authors:  Lene Martini; Jennifer L Whistler
Journal:  Curr Opin Neurobiol       Date:  2007-12-18       Impact factor: 6.627

10.  Analogues of beta-LPH61-64 possessing selective agonist activity at mu-opiate receptors.

Authors:  B K Handa; A C Land; J A Lord; B A Morgan; M J Rance; C F Smith
Journal:  Eur J Pharmacol       Date:  1981-04-09       Impact factor: 4.432

View more
  53 in total

Review 1.  Functional selectivity of GPCR signaling in animals.

Authors:  Lei Zhou; Laura M Bohn
Journal:  Curr Opin Cell Biol       Date:  2013-12-22       Impact factor: 8.382

Review 2.  Fine-tuning somatostatin receptor signalling by agonist-selective phosphorylation and dephosphorylation: IUPHAR Review 5.

Authors:  Stefan Schulz; Andreas Lehmann; Andrea Kliewer; Falko Nagel
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

3.  Agonist Binding and Desensitization of the μ-Opioid Receptor Is Modulated by Phosphorylation of the C-Terminal Tail Domain.

Authors:  William T Birdsong; Seksiri Arttamangkul; James R Bunzow; John T Williams
Journal:  Mol Pharmacol       Date:  2015-05-01       Impact factor: 4.436

Review 4.  Gaddum Memorial Lecture 2014: receptors as an evolving concept: from switches to biased microprocessors.

Authors:  Terry Kenakin
Journal:  Br J Pharmacol       Date:  2015-07-21       Impact factor: 8.739

5.  Chronic Treatment with Morphine Disrupts Acute Kinase-Dependent Desensitization of GPCRs.

Authors:  Emily R Leff; Seksiri Arttamangkul; John T Williams
Journal:  Mol Pharmacol       Date:  2020-05-03       Impact factor: 4.436

Review 6.  Efficacy and ligand bias at the μ-opioid receptor.

Authors:  E Kelly
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

7.  FK506-binding protein 12 modulates μ-opioid receptor phosphorylation and protein kinase C(ε)-dependent signaling by its direct interaction with the receptor.

Authors:  Yu Qiu; Wei Zhao; Yan Wang; Jian-Rong Xu; Eddie Huie; Shan Jiang; Ying-Hui Yan; Horace H Loh; Hong-Zhuan Chen; Ping-Yee Law
Journal:  Mol Pharmacol       Date:  2013-10-10       Impact factor: 4.436

Review 8.  Novel GPCR paradigms at the μ-opioid receptor.

Authors:  G L Thompson; E Kelly; A Christopoulos; M Canals
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

9.  Thalidomide Promotes Morphine Efficacy and Prevents Morphine-Induced Tolerance in Rats with Diabetic Neuropathy.

Authors:  Jianhui Zhao; Hong Wang; Tieying Song; Yunliang Yang; Kunfeng Gu; Pengyu Ma; Zaiwang Zhang; Limin Shen; Jiabao Liu; Wenli Wang
Journal:  Neurochem Res       Date:  2016-08-30       Impact factor: 3.996

10.  Ethanol reversal of cellular tolerance to morphine in rat locus coeruleus neurons.

Authors:  Javier Llorente; Sarah Withey; Guadalupe Rivero; Margaret Cunningham; Alex Cooke; Kunal Saxena; Jamie McPherson; Sue Oldfield; William L Dewey; Chris P Bailey; Eamonn Kelly; Graeme Henderson
Journal:  Mol Pharmacol       Date:  2013-05-28       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.